4-[4-(1,2-Dimethyl-1,2,3,6-tetrahydropyridin-4-yl)-2-(4-fluorophenyl)-1H-pyrrol-3-yl]pyridine

ID: ALA1089567

PubChem CID: 9884651

Max Phase: Preclinical

Molecular Formula: C22H22FN3

Molecular Weight: 347.44

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1CC(c2c[nH]c(-c3ccc(F)cc3)c2-c2ccncc2)=CCN1C

Standard InChI:  InChI=1S/C22H22FN3/c1-15-13-18(9-12-26(15)2)20-14-25-22(17-3-5-19(23)6-4-17)21(20)16-7-10-24-11-8-16/h3-11,14-15,25H,12-13H2,1-2H3

Standard InChI Key:  KATGXKGSQXAWIA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   11.3195  -16.8173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0011  -17.2808    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6527  -16.7757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3735  -15.9997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5495  -16.0259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1283  -15.3188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5353  -14.5987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1151  -13.8883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2883  -13.8969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8832  -14.6218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3058  -15.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6082  -17.2340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8897  -16.8240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1776  -17.2411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1826  -18.0681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9058  -18.4761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6150  -18.0567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7925  -15.2866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6195  -15.2919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0351  -14.5821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6284  -13.8628    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.8015  -13.8576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3811  -14.5718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4705  -18.4867    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.0470  -13.1506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3936  -13.1392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  2  0
  6  7  2  0
 13 14  1  0
  2  3  1  0
 14 15  2  0
  7  8  1  0
 15 16  1  0
  3  4  2  0
 16 17  2  0
 17 12  1  0
  1 12  1  0
 18 19  2  0
  8  9  2  0
  4  5  1  0
  9 10  1  0
  5  1  2  0
 10 11  2  0
 11  6  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
  4 18  1  0
  5  6  1  0
 15 24  1  0
  1  2  1  0
 21 25  1  0
 22 26  1  0
M  END

Associated Targets(Human)

Blood (2950 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 347.44Molecular Weight (Monoisotopic): 347.1798AlogP: 4.99#Rotatable Bonds: 3
Polar Surface Area: 31.92Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.97CX LogP: 3.99CX LogD: 2.41
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.72Np Likeness Score: -0.23

References

1. Nakao A, Ohkawa N, Nagasaki T, Kagari T, Doi H, Shimozato T, Ushiyama S, Aoki K..  (2010)  Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 2.,  20  (8): [PMID:20346666] [10.1016/j.bmcl.2010.03.022]

Source